Flunarizine
Generic name
Flunarizine
Brand name
ATC Code
N07CA03
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Migraine prophylaxis |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIVERTIGO PREPARATIONS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Antivertigo preparations | ||
|---|---|---|
| N07CA52 | ||
| N07CA02 | ||
References
- Boccia G, et al, Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine, Cephalalgia, 2006, Oct;26(10), 1214-9
- Caers LI, et al, Flunarizine, a calcium-entry blocker, in childhood migraine, epilepsy, and alternating hemiplegia, Clin Neuropharmacol, 1987, Apr;10(2), 162-8
- Guidetti V, et al, Flunarizine and migraine in childhood. An evaluation of endocrine function, Cephalalgia, 1987, Dec;7(4), 263-6
- Holmes B, et al, Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use, Drugs, 1984, Jan;27(1), 6-44
- Lastra Martinez L, et al, [Flunarizine and dihydroergotamine in the treatment of migraine in children], An Esp Pediatr., 1990, Mar;32(3), 213-8
- Pothmann R., [Prevention of migraine with flunarizine and acetylsalicylic acid. A double-blind study], Monatsschr Kinderheilkd., 1987, Sep;135(9), 646-9
- Sorge F, et al, Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study, Cephalalgia, 1988, Mar;8(1), 1-6
- Visudtibhan A, et al, Flunarizine for prophylactic treatment of childhood migraine, J Med Assoc Thai, 2004, Dec;87(12), 1466-70
Changes
Therapeutic Drug Monitoring
Overdose
